date:Mar 12, 2013
seeking funding to begin clinical trials of GCP on human prostate cancer patients. Because GCP is a natural extract rather than a pharmaceutical product, the testing and approval process should be able to proceed more quickly than with standard drugs.
We should know within the first eight months or so of human clinical trials if GCP works to reduce PSA levels, researcher Ralph de Vere White said. We want to see up to 75 percent of metastatic prostate cancer patients lower their PSA levels, and